EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The role of Limch1 alternative splicing in skeletal muscle function

Matthew S Penna iD, Rong-Chi Hu iD, George G Rodney iD, Thomas A Cooper iD

Life Science Alliance · 2023

DOI: 10.26508/lsa.202201868 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Life Science Alliance, 2023. Verfasst von Matthew S Penna und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology & Immunology, Baylor College of Medicine, Houston, TX, USA. Hauptthemen laut MEDLINE: Alternative Splicing, Myotonic Dystrophy. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAMS NIH HHS, NIDDK NIH HHS, NHLBI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Postnatal skeletal muscle development is a highly dynamic period associated with widespread alternative splicing changes required to adapt tissues to adult function. These splicing events have significant implications because the reversion of adult mRNA isoforms to fetal isoforms is observed in forms of muscular dystrophy. LIMCH1 is a stress fiber–associated protein that is alternatively spliced to generate uLIMCH1, a ubiquitously expressed isoform, and mLIMCH1, a skeletal muscle–specific isoform containing six additional exons simultaneously included after birth in the mouse. CRISPR/Cas9 was used to delete the six alternatively spliced exons of LIMCH1 in mice, thereby forcing the constitutive expression of the predominantly fetal isoform, uLIMCH1. mLIMCH1 knockout mice had significant grip strength weakness in vivo, and maximum force generated was decreased ex vivo. Calcium-handling deficits were observed during myofiber stimulation that could explain the mechanism by which mLIMCH1 knockout leads to muscle weakness. In addition, LIMCH1 is mis-spliced in myotonic dystrophy type 1, with the muscleblind-like (MBNL) family of proteins acting as the likely major regulator of Limch1 alternative splicing in skeletal muscle.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alternative SplicingMyotonic DystrophyAnimalsMiceMice, KnockoutMuscle, SkeletalProtein IsoformsRNA SplicingMuscle ProteinsLIM Domain Proteins

Substanzen

Protein IsoformsLimch1 protein, mouseMuscle ProteinsLIM Domain Proteins

Autor:innen und Institutionen

  • Department of Pathology & Immunology, Baylor College of Medicine, Houston, TX, USA.
  • Medical Scientist Training Program, Baylor College of Medicine, Houston, TX, USA.
  • Department of Integrative Physiology, Baylor College of Medicine, Houston, TX, USA.
  • Department of Integrative Physiology, Baylor College of Medicine, Houston, TX, USA rodney@bcm.edu.
  • Department of Pathology & Immunology, Baylor College of Medicine, Houston, TX, USA tcooper@bcm.edu.
  • Department of Molecular & Cellular Biology, Baylor College of Medicine, Houston, TX, USA.

ORCID-Profile: Matthew S Penna, Rong-Chi Hu, George G Rodney, Thomas A Cooper

Förderung

  • NIAMS NIH HHS
  • NIDDK NIH HHS
  • NHLBI NIH HHS
  • NIEHS NIH HHS
  • NCI NIH HHS
  • NHGRI NIH HHS
  • NIH
  • National Institutes of Health Cancer Center

Zitieren

APA

Penna, M. S., Hu, R. C., Rodney, G. G., & Cooper, T. A. (2023). The role of Limch1 alternative splicing in skeletal muscle function. Life Science Alliance. https://doi.org/10.26508/lsa.202201868

Vancouver

Penna MS, Hu RC, Rodney GG, Cooper TA. The role of Limch1 alternative splicing in skeletal muscle function. Life Science Alliance. 2023. doi:10.26508/lsa.202201868

BibTeX
@article{Penna2023,
  author = {Penna, Matthew S and Hu, Rong-Chi and Rodney, George G and Cooper, Thomas A},
  title = {The role of Limch1 alternative splicing in skeletal muscle function},
  journal = {Life Science Alliance},
  year = {2023},
  doi = {10.26508/lsa.202201868}
}
Kostenlos starten →